1. Adley, M., Jones, G., & Measham, F. (2023). Jump-starting the conversation about harm reduction: Making sense of drug effects. Drugs: Education, Prevention and Policy, 30(4), 347–360.
2. Chrzanowska, A., Man, N., Akhurst, J., Sutherland, R., Degenhardt, L., & Peacock, A. (2023). Trends in overdose and other drug-induced deaths in Australia, 2002–2021.
3. Dietze, P., Gerra, G., Poznyak, V., Campello, G., Kashino, W., Dzhonbekov, D., Kiriazova, T., Nikitin, D., Terlikbayeva, A., & Krupchanka, D. (2022). An observational prospective cohort study of naloxone use at witnessed overdoses, Kazakhstan, Kyrgyzstan, Tajikistan, Ukraine. Bulletin of the World Health Organization, 100(3), 187.
4. EMCDDA. (2014). Video: Take-home naloxone programmes in Europe–Overdose prevention. Retrieved January 23, 2024 from https://www.emcdda.europa.eu/media-library/video-take-home-naloxone-programmes-europe-%E2%80%94-overdose-prevention_en
5. EMCDDA. (2021). European drug report 2021: Trends and developments. https://www.emcdda.europa.eu/publications/edr/trends-developments/2021_en